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Abstract
Aging is an enormously complicated process. Despite a great many of theories (among 
them “Program Theories”, “Combined Theories”, “Damage Theories”, “Inflamm-Aging”, 
“Garb-Aging” and the “Rising Deleteriome”), so far there is none which is able to explain 
this phenomenon satisfactorily and completely. A different approach to address the com-
plexity of aging is to characterize the major “Hallmarks of Aging”. These are genomic 
instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutri-
ent sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion and an 
altered intercellular communication. From research on these hallmarks, new avenues were 
opened on how to interfere with the aging process. Some of these possible therapeutic 
interventions are described here too.
Keywords: aging, aging theories, hallmarks of aging, senescence, healthy aging,  
anti-aging interventions
1. Introduction
Aging has ever been a puzzling phenomenon for mankind. It is already an important topic 
in ancient Greek mythology: Eos goddess of the dawn did fall in love with Tithonus son of 
Laomedon king of Troy. Eos asked Zeus to grant Tithonus immortality, she did forget to ask 
for eternal youth too, however. Therefore Tithonus was living happily, but the process of 
aging continued inexorably. Over time, there was not much more left of him than a croaking 
voice and finally, he was transformed into a cicada.
The question of then still remains today: Is aging really unavoidable? Not necessarily, as some 
organisms do not seem to age. Most prominent of them is the tiny fresh water polyp Hydra. It 
does already have a simple nervous system and does not display any signs of aging.
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This remarkable feature of Hydra is due to the fact that its stem cells have an unlimited capac-
ity for self-renewal. In this respect, the transcription factor FoxO plays a crucial role [1]. In 
contrast to Hydra, all vertebrates are aging although at a very different rate. The lifespan of 
the mouse is between 2 and 4 years, whereas the lifespan of the Greenland shark is beyond 
400 years [2]. If we look at mammals, the lifespan can vary up to 100-fold: The Etruscan shrew 
has a lifespan up to 2 years, whereas for the bowhead whale a lifespan beyond 200 years 
has been estimated [3]. In general, large animals are living longer than small ones. A dog 
lives considerably longer than a mouse and an Elephant lives much longer than a dog. There 
is, however, a great variety in lifespans: as already mentioned, the lifespan of the mouse is 
in the range of 2–4 years, whereas the related naked mole rat which is roughly the same 
size lives up to 30 years [4]. Some organisms are aging very fast and some are aging quite 
slowly. Nevertheless for all of them is true: Aging is characterized by a reduction of fitness, 
an increase of age-related diseases and a massive increase of the risk of dying. Considering 
humans, the risk of dying of an 80-year-old is 300 times higher than for a 20-year-old person 
[5]. With this chapter, we want to give a short overview on major topics of current aging 
research. Furthermore, we want to point out possibilities that are arising from this research 
field which will probably help to increase the healthy lifespan quite considerably.
2. Theories of aging
In the quest to explain aging, many theories have been developed. In 1990, Zhores Medvedev 
collected all these different theories and their number exceeded 300 [6]. In the meantime, a 
number of new ones have been presented. Considering only this fact, one can easily imag-
ine that aging is a very complex process. Accordingly, aging is far away from being under-
stood completely. In a recent publication, the different theories are divided into “Program 
Theories”, “Combined Theories” and “Damage Theories” [7]. The program theories are based 
on the assumption that aging is genetically programed. Among these theories is the theory 
of replicative senescence [8]. Already in 1965, Hayflick has observed that cells in cell culture 
divide about 40–50 times after which they enter a permanent cell cycle arrest from which they 
cannot escape any more. This phenomenon has been explained by the shortening of telomeres 
taking place at each cell division. If telomeres are becoming too short, the shelterin complex is 
lost and the cell recognizes this as a DNA double-strand break triggering a permanent DNA 
damage response [9]. Furthermore, it turned out that cellular senescence can be triggered by 
a variety of different stress factors, among them oxidative stress or overexpression of cellular 
oncogenes. Cellular senescence is a potent anti-tumor mechanism preventing damaged cells 
from dividing any further. Senescent cells undergo dramatic phenotypic changes and start 
secreting many proteins (among them cytokines and chemokines), this is known as the senes-
cence-associated secretory phenotype (SASP). These proteins attract immune cells like macro-
phages, neutrophils and natural killer cells, which are supposed to remove the senescent cells. 
Nevertheless, senescent cells are accumulating with increasing age and triggering pathological 
changes in the particular organ. In a mouse model, it has been demonstrated that pathological 
changes in lung [10], kidney, heart and adipose tissue [11] can be prevented if senescent cells are 
cleared from the organism. There is convincing evidence that senescent cells play a major role 
in reducing the function of old organs and the emergence of age-associated pathologies [9, 12]. 
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The formation of senescent cells might also be seen as kind of antagonistic pleiotropy. This 
“program” aging theory claims that during evolution mutations are taking place which pro-
vide an advantage for early stages of life but are detrimental late in life [13]: Damaged cells 
becoming senescent prevent tumor formation early in life but they produce a number of 
adverse effects late in life. The “disposable soma theory” [14] also a “program” theory claims 
that resources for an organism are limited and they have to be allocated between maintenance 
of the organism and reproduction. Furthermore does the “neuroendocrine theory of aging” 
[15] belong to the “program theories”. It states that aging is regulated by hormones similar 
to puberty and menopause. As a matter of fact, animals that reach sexual maturity in a short 
period of time have also a short lifespan. The mouse reaches sexual maturity within 6–8 weeks 
and has a lifespan of 2–4 years, whereas for the Greenland shark it takes some 150 years to 
reach sexual maturity but then its lifespan exceeds 400 years [2]. Interesting in this respect is 
that in parabiosis experiments, it was demonstrated that blood from young mice has a reju-
venating effect on old mice [16]. Recent research furthermore points to the fact that changes 
in the regulation of gene expression during aging are predominantly affecting genes which 
are responsible for growth and development [17]. The age an organism is able to live up to is 
without any doubt depending on its genome. Even under identical environmental conditions, 
a human will be living much much longer than a mouse. But up to now, there has been no 
gene identified that would actively regulate the aging process.
On the other end of the spectrum of aging theories are the damage theories. Among them the 
most prominent is the free radical theory of aging [18, 19]. According to it, reactive oxygen 
species (ROS) a byproduct of oxidative phosphorylation in mitochondria, damage DNA, lip-
ids and proteins. They will be briefly discussed as follows:
1. DNA damage: It is of utmost importance that DNA damage will be repaired efficiently. If 
not this causes a rapidly accelerated aging process as can be observed in patients with a 
progeria syndrome (Werner Syndrome). Therefore we have a number of DNA repair sys-
tems (direct reversal pathway, mismatch repair, base excision repair, nucleotide excision 
repair, homologous recombination and non-homologous end joining) which repair DNA 
damage very efficiently [20]. Altogether there are more than 100 DNA repair enzymes 
known [21] which take care that DNA damage is not a major cause for aging until their ac-
tivity diminishes during aging. Most probably contributing to the aging process are DNA 
double-strand breaks [22].
2. Lipid peroxidation: ROS predominantly attack unsaturated fatty acids in the membranes 
of a cell. By this lipid peroxidation fatty acids literally become chopped down producing 
chemically very active aldehydes [23]. These aldehydes react with DNA and proteins re-
sulting in irreversible modifications. Proteins modified this way often loose their function 
and form aggregates which are not degradable by the cell which is in particular problem-
atic in the brain. It has been demonstrated that lipid peroxidation triggers neurodegenera-
tion [24].
3. Protein oxidation: Proteins are also attacked by ROS. In particular, sulfur-containing ami-
no acids are being oxidized. The first stage of oxidation can be reversed enzymatically but 
later stages not any more [25]. Oxidatively damaged proteins too have the tendency to de-
nature and to form aggregates which the cell is not able to degrade. Such aggregates may 
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cause death of the cell eventually as is the case in Alzheimer patients. ROS are damaging 
cells in many locations in particular if they are produced excessively. On the other hand, 
ROS are important signaling molecules, therefore their complete removal by antioxidants 
is definitely counterproductive. In recent years, a modification of the free radical theory of 
aging gained attention: It claims that not ROS are driving the aging process but the dis-
turbed redox homeostasis is a major culprit [26, 27].
Also a damage theory is the theory of “Inflamm-Aging” which claims that aging is caused 
by ongoing low level sterile inflammatory processes [28]. In fact all degenerative diseases in 
aging have an inflammatory component as there are: Alzheimer, Parkinson, arteriosclero-
sis, arthritis, multiple sclerosis, osteoporosis and diabetes type II [29]. Responsible for many 
inflammatory reactions are debris of dead cells and un-degradable protein aggregates which 
have not been removed completely. This was the basis to coin the term “Garb-Aging” (from 
garbage and aging) as an addition to inflamm-aging [30]. None of the so far mentioned theo-
ries, however, is able to explain all facets of the aging process. Therefore a new perspective 
was presented recently: “Aging: progressive decline in fitness due to the rising deleteriome” 
[31]. According to this theory neither the synthesis of biomolecules nor the repair systems 
in a cell are working absolute flawlessly. Furthermore there are chemical reactions between 
many biomolecule. The resulting compounds cannot be removed completely. That means 
that unwanted reaction products as well as non-repaired damage (= deleteriome) increases 
with time and causes the aging process.
3. Hallmarks of aging
A completely different approach than to explain aging by theories is to describe it by its major 
characteristic features: “The Hallmarks of Aging” [32]:
3.1. Genomic instability
DNA is permanently exposed to a great variety of damage caused by ROS, lipid peroxidation 
products, environmental mutagens, hydrolytic reactions, UV irradiation and many more.
Besides chemical modifications to DNA, there can be single- and double-strand breaks, depu-
rination as well as cross links between bases. Addition, deletion or substitution of bases is 
causing mutations. All together, these changes can also lead to epigenetic alterations causing 
changes in gene expression. To repair this damage efficiently is of utmost importance as can 
be seen in progeria or premature aging syndromes. In these diseases, defects in DNA repair 
systems are causing a dramatically accelerated aging process [33].
Usually, DNA damage is repaired very efficiently, however, the activity of the repair systems 
declines during aging [34].
3.2. Telomere attrition
Telomeres are protective caps on the ends of chromosomes preventing degradation or fusion 
of chromosome ends. At every cell division, telomeres are getting shorter and if they reach a 
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critical length the cells, are not able to divide anymore. This telomere attrition eventually leads 
to replicative senescence. The degree of shortening is proportionate to risks of a number of 
aging diseases [35]. In particular, short telomeres lead to bone marrow failure causing anemia 
and immune senescence and to enterocolitis in the intestinal epithelium. Furthermore, short 
telomeres are causing premature onset of emphysema and pulmonary fibrosis in the lung, 
fibrosis in the liver and also osteoporosis [36]. In addition, short telomeres have an impact on 
gene expression through telomere position effects on nearby genes [37]. Through the expression 
of telomerase in mice, the normal aging process could be delayed [38]. In humans, 11 muta-
tions inactivating a single gene are known which directly affect telomere maintenance and they 
lead to age-related diseases and accelerated aging [35]. Also a telomere biology disorder is the 
Hoyeraal-Hreidarsson (HH) syndrome which is caused by mutations in genes with telomeric 
functions. It is characterized by very short telomeres and affected individuals die in childhood 
mostly due to bone marrow failure [39]. Interestingly, it has been shown that in wild animals, 
telomeres shorten more slowly in slow-aging than in fast-aging ones [40].
3.3. Epigenetic alterations
Epigenetic changes are comprising alterations in histone marks, DNA methylation, nucleo-
some positioning and non-coding RNAs [41]. Histone modifications and methylation patterns 
of CpG islands have a tremendous influence on gene expression. For a set of 353 CpG islands, 
a clear correlation with age could be demonstrated. Of these, 193 CpGs get hypermethylated 
and 160 get hypomethylated during aging [42]. According to its reliable changes in methyla-
tion status, this set has been termed the epigenetic clock [27, 42, 43]. With this epigenetic clock, 
it is possible to predict the biological age and an age-related functional decline. Furthermore, 
it has been demonstrated that lifestyle factors like diet, exercise and education have an influ-
ence on this epigenetic clock [44]. In addition to DNA, the histones are subject to modifi-
cations (acetylation, methylation, phosphorylation and more). There are also a number of 
methylation marks that are changing with age. But the present picture is less clear than with 
DNA methylation [41]. A lot of attention has been focused on sirtuins. Sirtuins are class III his-
tone deacetylases, which need NAD+ as a cofactor and remove acetyl groups from previously 
modified lysines in the histone N-terminal tails. By removing the acetyl groups, lysines regain 
their positive charge and bind more tightly to DNA. The result is a more compact chromatin 
structure and down-regulation of gene expression. The removal of histone acetyl groups by 
sirtuins results in an extension of lifespan [45]. In total, seven sirtuins are known, of which 
SIRT1, SIRT6 and SIRT7 are localized in the nucleus. SIRT2 is predominantly found in the 
cytoplasm and is only localized to chromatin during the G/M phase of the cell cycle. SIRT3, 
SIRT4 and SIRT5 are the three mitochondrial deactelyases. Sirtuins do not only deacetylate 
histones but regulate the activity of a number of other proteins too. This way they play a cen-
tral role in regulatory networks important for aging and longevity [46]. Mutant mice where 
single sirtuin genes have been deleted show a number of different pathologies connected to 
metabolism, cancer and inflammation [47].
3.4. Loss of proteostasis
Proteins not only have to be synthesized but they have to be removed and degraded eventually. 
Among many others, there are two major ways to remove damaged proteins: either to degrade 
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them by the proteasome or via autophagy [48, 49]. In addition, the cell has chaperones. These 
proteins help to fold proteins correctly or enable the renaturation of already denatured pro-
teins. If refolding is impossible, chaperons are also able to target misfolded proteins to the pro-
teasome. Therefore proteostasis, the maintenance of an intact proteome, includes not only 
synthesis and degradation of proteins but also folding and conformational maintenance. The dis-
turbance of proteostasis is considered to be a major cause of aging [50, 51]. Not only the amount 
of chaperones is decreasing [52], but also the proteasomal activity and autophagy are declin-
ing during aging. This decline causes an accumulation of denatured proteins which have the 
tendency to form aggregates that cannot be removed by the cell anymore. These aggregates are 
detrimental to the cell and can even cause death of the cell (e.g. nerve cells in Alzheimer and 
Parkinson patients) [53]. Furthermore, it has been demonstrated that long-living animals have less 
denatured proteins than short-living ones [54]. In addition, the activity of the proteasome is remark-
ably higher in the long-living naked mole rat than in the short-lived mouse [55]. Particularly interest-
ing in this respect is that experimental interventions which reduce the aging process are stimulating 
autophagy like caloric restriction, rapamycin, metformin, resveratrol and spermidine [56].
3.5. Deregulated nutrient sensing
Nutrient sensing is of utmost importance for every cell. The major nutrient sensing pathways 
that are also longevity pathways are [57]:
• IGF-1 and insulin signaling pathway
• mTOR pathway
• AMP-activated protein kinase (AMPK) pathway
• NAD+ dependent sirtuins
IGF-1 is like insulin a growth factor for many cells and acts via the insulin and IGF-1 signaling 
(IIS) pathway. The down-regulation of this pathway leads to a prolonged lifespan [58]. IGF-1 
but also EGF and high amino acid levels are activating the mTOR pathway which stimulates 
protein synthesis and growth in general but down-regulates autophagy [59]. AMPK is the 
sensor and regulator for energy metabolism and homeostasis of the cell. AMPK activity can 
extend the lifespan of yeast, C. elegans and drosophila and the healthspan of mice [60].
NAD-dependent sirtuins are a family of deacylases which not only deacetylate histones but 
modify a large number of non-histone proteins too. They show impressive activities to pre-
vent diseases and some aspects of aging [61].
During aging, the synthesis of these sensor proteins is reduced however [62].
The different signal transduction pathways that are sensing the availability of nutrients are 
deregulated during aging by metabolic diseases [63].
3.6. Mitochondrial dysfunction
As mitochondria are not only the power plants of the cell but also important signaling centers 
they play a central role in the aging process. For energy production in form of ATP, they reduce 
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oxygen to water. If accidentially oxygen gets only one electron, it leads to the production of ROS 
instead of water. This has inspired Harman already in 1956 to present his “Free Radical Theory 
of Aging,” which he has repeatedly improved [18]. Furthermore, it has been demonstrated that 
ROS are not only causing damage but also are important signaling molecules, which are able to 
regulate many pathways. For example, ROS can induce autophagy (mitophagy) [64].
The events of biogenesis, fusion, fission and mitophagy are collected under the term mito-
chondrial dynamics [65]. Function as well as quality of mitochondria is regulated by mito-
chondrial dynamics. Nutrients in excess cause fragmentation (fission) of mitochondria and 
a low level of nutrients leads to fusion and elongation [66]. Mitochondrial dynamics is also 
influenced by external signals like hormones, nutrients and physical exercise. A number of 
pathways are involved like mTOR, AMP-activated kinase and sirtuins [67]. In particular, sir-
tuins play an important role as they do not regulate a few target enzymes but regulate func-
tional clusters (e.g. TCA cycle, fatty acid metabolism, electron transport chain and others). 
This way they are involved in the regulation of ROS-mediated signaling pathways as well 
as in the detoxification of damaging ROS. Furthermore they regulate metabolic plasticity. 
SIRT3, for example, promotes switching to fatty acid oxidation upon caloric restriction [68]. 
The modulation of metabolic changes plays a crucial role in senescence too. In addition, defect 
mitochondria are stimulating inflammatory reactions which are triggering inflamm-aging 
[69]. Altogether, mitochondrial dysfunction leads to a number of age-related diseases includ-
ing metabolic, cardiovascular and neurodegenerative pathologies, sarcopenia and fibrosis in 
different organs [65].
All these facts demonstrate that the quality of mitochondria has a tremendous impact on the 
aging process [70, 71].
3.7. Cellular senescence
Cellular senescence is characterized by an irreversible arrest of the cell cycle. This means that 
cellular senescence can only affect cells that are able to divide like stem cells, progenitor cells 
or cells that are not yet terminally differentiated. This phenomenon has been discovered with 
cells in cell culture. It turned out that they cannot divide without limits but stop growing after 
about 40–50 cell divisions [72].
The irreversible cell cycle arrest can be induced by erosion of telomeres, substantial DNA dam-
age, oxidative stress, overexpression of oncogenes, mitochondrial dysfunction and proteotox-
icity [73]. Cells in the state of senescence change their morphology, they are getting larger and 
there are massive changes in the organization of chromatin [74]. Furthermore, they start to 
secret a large number of proteins. The sum of all these proteins is called the senescence-asso-
ciated secretory phenotype (SASP). Among these proteins are pro-inflammatory cytokines, 
chemokines, growth factors and matrix metalloproteases (MMPs). The pro-inflammatory 
cytokines are causing local sterile inflammations which contribute substantially to “inflamm-
aging”. They attract cells of the immune system which are killing senescent cells. The over-
proportional increase of senescent cells during aging is probably due to a decline in immune 
function [75]. An important additional feature of senescent cells is the active suppression of 
apoptosis [76]. At the level of gene expression, permanent cell cycle arrest is mediated by the 
protein p16Ink4a which is an inhibitor of the cyclin dependent kinases 4 and 6 (CDK4 and CDK6). 
The Basics of Biogerontology
http://dx.doi.org/10.5772/intechopen.76246
121
In healthy young cells, p16Ink4a expression is low or undetectable but increases dramatically in 
senescent cells [9]. This way it is evident that an essential function of senescence (maybe the 
most important one for the organism) is to pull the emergency brake to prevent uncontrolled 
cell division which otherwise could cause tumor formation. Senescent cells have also an impor-
tant additional function in wound healing. After a wound has been inflicted many cells are 
produced in excess to close the wound. During the subsequent remodeling process, the surplus 
of cells is entering senescence and will be removed by the immune system. For years it has been 
discussed by researchers if cellular senescence has any influence on the aging process itself. 
During the past few years, scientists came to the conclusion that cellular senescence is one of 
the major causes of aging [77]. In genetically modified mice, it was already possible to delete 
senescent cells (p16Ink4a positive cells). These animals showed less age-related pathologies, an 
improved healthspan and a prolonged median lifespan [9, 11]. Therefore, there are already 
a number of different interventions under investigation how senescent cells can be removed 
from the human body [78, 79]. To succeed in this respect could dramatically improve human 
healthspan. Senescent cells are detrimental to the function of organs they are residing in and 
this way they have a tremendous impact on age-dependent degenerative diseases [12, 78].
3.8. Stem cell exhaustion
Stem cells are of utmost importance for tissue homeostasis and regeneration and stem cell 
exhaustion is among the most significant hallmarks of aging. Stem cell exhaustion is leading 
to a reduced regenerative capacity during the aging process. Premature stem cell exhaustion 
is also seen in age-related diseases [80]. Stem cells are usually very small remaining in a state 
of quiescence. This state is characterized by low metabolism and the presence of few mito-
chondria. From dormancy, they can be activated to replace lost stem cells or to produce transit 
amplifying cells which will provide many cells for repair or regeneration of their particular 
tissue. During this differentiation process, they are going through a developmental program 
which is tuning them precisely to their new function [81].
There are tissues with a very high turnover of cells like bone marrow, intestine and the epi-
dermis of the skin. There are also tissues where stem cells get activated rarely like muscle 
and brain. Essential for survival and quiescence of stem cells is their immediate environment 
which is defined as the stem cell niche. The stem cell niche comprises proteins of the extra-
cellular matrix and surrounding cells which secrete a number of growth regulating proteins 
(Wnts, BMPs, EGF and Notch). It is essentially regulating the state of quiescence [82, 83]. 
Different drivers of aging (telomere attrition, cellular senescence, DNA damage, epigenetic 
alterations, nutrient sensing and disturbed proteostasis) have their impact on stem cells too 
and are responsible for stem cell aging [84]. As stem cells usually stay in the state of quies-
cence and divide rarely, many pro-aging impacts affect the stem cells via their niche. Muscle 
stem cells, so called satellite cells, rarely divide, but proliferate massively upon demand. They 
produce myoblasts which are the precursor cells necessary for the regeneration process of the 
muscle. If old satellite cells are transplanted into young muscle tissue their regenerative capac-
ity increases which demonstrates the influence of the young niche [85, 86]. The opposite is 
true for transforming growth factor beta (TGF-beta1). This factor is produced by the niche and 
reduces the proliferative potential of satellite cells. During aging under certain circumstances 
the niche increases the production of fibroblast growth factor 2 (FGF2). This triggers the stem 
cells to leave quiescence and start to divide which eventually leads to a reduction of satellite 
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cells available for the regeneration of muscle tissue [87]. In a similar way, the prolonged signal-
ing of the growth hormone (GH)/insulin/insulin-like growth factors (IGF) axis is considered 
to cause a depletion of stem cells [88]. There are also areas in the adult brain where stem cells 
are residing: in the dentate gyrus of the hippocampus in the hypothalamus and in the subven-
tricular zone of the lateral ventricles [89]. Like in other tissues, there are age-related changes in 
the stem cell niche and the number of neural stem cells is declining during aging. Not only the 
numbers of stem cells are decreasing during aging but also the proliferation of the developing 
precursor cells will be damped via an elevated concentration of TGF-beta1. This way the pro-
duction of new neurons is reduced while the generation of oligodendroglia remains at about 
the same level [90]. Furthermore, sterile micro-inflammation in the hypothalamus can cause a 
reduction of neural stem cells which in turn leads to a reduction of cognitive functions [91]. In 
addition to the number of stem cells and the contribution of the stem cell niche, the regenera-
tive capacity will be influenced by systemic factors. Via parabiosis experiments (connecting 
an old mouse to a young one), it was possible to correct malfunction of old satellite cells in 
muscle tissue. These satellite cells could be reactivated again. In a similar way, it was possible 
to improve the function of stem cells and neurogenesis in old brains. The proteins responsible 
for this activity could be identified as growth differentiation factor 11 (GDF11) and oxytocin 
[92]. There are numerous factors that regulate the biological function of stem cells. Presently, 
it seems that the most important ones are metabolism and epigenetic changes [80]. As exces-
sive nutrient sensing leads to premature depletion of adult neural stem cells [89] and chronic 
activation of mTOR leads to loss of stem cells in the airway epithelium of the mouse [93].
3.9. Altered intercellular communication
The regenerative capacity of stem cells is independently influenced by intrinsic and extrinsic 
determinants [92]. An intrinsic determinant is the maintenance of autophagy. A failure of 
autophagy in old satellite cells leads to senescence eventually [94]. Among the extrinsic fac-
tors, growth hormone/insulin/IGF-1 (somatotrophic axis) is a center piece for the regulation 
of growth in the mammalian organism. Mouse mutants with defects in the biosynthesis of 
the growth hormone (Ames dwarf mice, Snell dwarf mice or GHRKO-mice (GH receptor 
deletion)) are considerably smaller than wild type mice but have an approximately 50% lon-
ger lifespan [95]. In humans, the amount of growth hormone and IGF-1 in the circulation is 
changing during aging. The highest level is reached during the second decade where growth 
is most prominent. Afterwards the concentration is going down continuously until it reaches 
a low plateau during the sixth decade. Humans with genetic polymorphisms resulting in a 
reduced activity of IGF-1 show a significantly increased lifespan. An elevated concentration 
of IGF-1 is correlated to a higher risk for some tumors [96]. There is also an altered com-
munication between muscle stem cells and the environment. Growth hormone is important 
for the maintenance of muscle mass [97]. IGF-1 is modulating the differentiation of muscle 
progenitor cells (myoblasts) and influencing satellite cells [98]. An increased aging of muscle 
stem cells is caused by an elevated concentration of Wnt-proteins (e.g. Wnt3A) [99]. As an 
antagonist of Wnt/β-catenin signaling acts the protein klotho. Unfortunately, the amount of 
klotho in the circulation is decreasing during aging. In the mouse, the silencing of the klotho 
gene triggered a rapid aging process [100]. Klotho is essential for the homeostasis of mineral 
metabolism (in particular phosphate) but it also modulates the signaling pathways of IGF-1 
and Wnt. The deletion of the klotho gene in mice reduces their lifespan to 2–3 months which 
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is only about 10% of their regular lifespan [101]. A remarkable activity has also been demon-
strated for GDF11 which improves regeneration in old organisms and serum levels of GDF11 
are significantly lower in old individuals [102]. An increased regenerative activity has been 
shown for bone [103], brain [104], skeletal muscle [105] and heart [106].
Furthermore, a number of chemokines (CCL2, CCL11, CCL12 and CCL19) have been identi-
fied via parabiosis experiments and they have been correlated with impaired neurogenesis 
in old individuals [107]. Other potential pro-aging factors that increase during lifetime are 
TGF-beta1, IL-6 and TNF-alpha [107]. Beta2microglobulin too is a systemic pro-aging factor 
triggering age-related cognitive impairment [108].
Another pro-aging factor is the plasminogen activator inhibitor 1 (PAI-1) which is secreted 
by senescent cells. It induces the accumulation of p16Ink4a leading to cellular senescence [109]. 
An anti-aging factor is kallistatin which inhibits oxidative stress and inflammation. It is also 
able to down-regulate the miRNA synthesis of miR21 and miR-34a, thereby reducing vascular 
senescence and aging [110]. The protein tissue inhibitor of metalloproteinase 2 (TIMP 2) was 
isolated from human umbilical cord. It is an anti-aging protein which revitalizes the hippo-
campus, increases synaptic plasticity and improves cognitive function [111]. The intercellular 
communication is also altered by numerous pro-inflammatory cytokines which are released 
by senescent cells. These cytokines are causing inflammatory processes [112]. Furthermore, 
inflammasomes in the cells of the innate immune system can be activated by DAMPs (dam-
age-associated molecular patterns) [113]. DAMPS are comprised of debris of necrotic cells, 
amyloide fibers, HMGB1, heat shock proteins, crystals of cholesterol and uric acid. Activated 
inflammasomes are causing the release of interleukins IL-1beta and IL-18 [114]. These inter-
leukins trigger inflammatory reactions in the surrounding tissue which are causing age-
related diseases [115], among them Alzheimer´s disease [116].
Exosomes provide an additional possibility for intercellular communication. They are small 
lipid vesicles which are secreted by the cell and they carry proteins and functional RNAs 
[117]. They can contact nearby cells or they can be distributed via the circulation across the 
whole organism. They help the cell to get rid of toxic protein waste [118] or to contribute to 
intercellular communication [119]. In the latter case, predominantly miRNAs play an impor-
tant function [120]. During aging, the amount of exosomes in the blood stay more or less 
constant. Their content, however, becomes more pro-inflammatory [121]. Recently, it has been 
shown that they also play a role in senescence and aging [122].
4. Possible therapeutic interventions
4.1. Physical exercise
The most simple and probably the most efficient way to attenuate aging is to perform physi-
cal exercise. A sedentary lifestyle with minimal physical activity on the contrary is detrimen-
tal for health comparable to smoking [123]. It is quite obvious that physical exercise is the 
best way to keep skeletal muscles in a healthy condition [124] and to prevent sarcopenia and 
frailty in old age [125]. Physical exercise does not only improve physiological parameters like 
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maximum oxygen consumption and reduced levels of cholesterol and triglycerides in the 
blood, but it also improves physical and psychical conditions in old age [126]. Although a 
number of physiological parameters can be improved considerably by physical training, the 
protective function for the cardiovascular system are about twice as high as can be explained 
by these parameters only. Therefore there are still many open questions concerning the 
molecular mechanisms which are activated by physical training [127]. Very well documented 
is, however, the positive effect on the brain and in particular on cognitive functions and the 
stimulation of neuronal growth in the hippocampus, an area critically important for memory 
processes [128]. Physical exercise increases hippocampal volume, functional connectivity and 
improved connectivity between the default mode network and the prefrontal cortex [129]. In 
this context, it should also be mentioned that physical exercise leads to a significant improve-
ment of memory functions in Alzheimer patients [130].
4.2. Caloric restriction/dietary restriction
Already in 1935 it has been demonstrated on rats that reducing the amount of food intake can 
extend the lifespan by 30% [131]. This experiment has been repeated many times and it turned 
out that animals are not only living longer but they also show less age-related deficits. During 
the past years, it has been demonstrated that the amount of calories is less important than the 
amount of proteins. Therefore the term caloric restriction has been replaced in most cases by 
the term dietary restriction. In addition to the amount of food, the timing of food uptake is 
important. Animals getting their food evenly distributed during the day did not show positive 
effects but animals fed only once a day did show the positive effects. Also did fasting every 
second day result in an increase of lifespan by 30% [132]. Altogether a great many experiments 
have been performed concerning this topic and results are sometimes contradictory. Some 
authors are pointing out explicitly that it is necessary to test many different combinations of 
carbohydrates and proteins in a single experiment. It has been demonstrated that a relation of 
1:10 (proteins:carbohydrates) results in the longest lifespan in mice. Remarkable in this respect 
is the fact that the traditional diet of the population of Okinawa consists of protein to carbohy-
drates in a relation of 9:85 and it is well documented that the people of Okinawa have the high-
est life expectancy worldwide [133]. It has to be mentioned that not only permanent dietary 
restriction is effective but intermittent fasting too. In rats and mice as well as in humans, there 
are profound health benefits. Results of intermittent fasting (2 days per week or every other 
day) decreased insulin levels, increased resistance to stress of heart and brain, reduced inflam-
mation, enhanced autophagy, mitochondrial health and DNA repair [134]. Concerning DNA 
repair, the following experiment is really remarkable: mice lacking the DNA excision repair 
gene Ercc1 are aging very fast with a lifespan of 4–6 months. If they are subjected to a dietary 
restriction of 30%, this treatment triples their lifespan [33]. The single cell senses the availability 
of nutrition via nutrient sensing pathways which are GH/insulin/IGF-1, mTOR, sirtuins and 
AMPK and via these pathways the metabolic influence on the aging process is regulated [57].
4.2.1. The somatotrophic axis (GH/insulin/IGF-1)
Attenuating the signaling of the somatotrophic axis results in an increased lifespan. This has 
been demonstrated in animal models, in genetic polymorphisms or functional mutations in 
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the IGF1R gene in humans [96]. Pharmaceutical interventions to block the signaling of this 
pathway are being tested but there are no drugs available yet to be used in humans [96].
4.2.2. mTOR
mTOR is a serine/threonine kinase which is “the grand conductor of metabolism and aging” 
and is either part of the multiprotein complex mTORC1 or mTORC2 [135]. Growth factors, 
insulin, IGF-1, amino acids and glucose are activating mTOR which in turn stimulates growth 
and inhibits autophagy.
Rapamycin binds to FKBP12 in this way inhibiting mTOR. Blockage of mTOR increases the 
lifespan in different organisms among them mice. But unfortunately there are numerous side 
effects which prohibit the use on a daily basis for healthy individuals [135].
4.2.3. Sirtuins
Sirtuins interact with IGF-1, mTOR and AMPK signaling pathways and regulate many other 
proteins involved in energy metabolism, DNA repair, cell survival, inflammation and tissue 
regeneration. SIRT1, for example, besides deacetylating histones H1, H3 and H4 modifies 
more than 50 other proteins [61]. Sirtuin-activating compounds (STACs) have gained much 
attention since their discovery 2003 and more than 14,000 STACs have been identified since 
then [61]. Essentially there are two different classes: sirtuin activators and compounds that 
raise NAD+ levels. Using rodents numerous studies have shown that STACs promote health 
during aging involving protection against cardiovascular disease, diabetes type 2, neurode-
generation and even cancer [61].
4.2.4. AMP-activated protein kinase (AMPK)
AMP-activated protein kinase is a heterotrimeric protein and a key enzyme in cellular energy 
sensing. The alpha subunit kinase domain contains a conserved threonine which is phosphor-
ylated by upstream kinases activating AMPK. The beta subunit binds the alpha and gamma 
subunits and has an additional domain to sense glycogen. The gamma domain has four sites 
that can bind AMP, ADP and ATP which provides AMPK with the ability to sense AMP:ATP 
and ADP:ATP ratios [136, 137]. These features make AMPK the centerpiece of “an energy-
sensing pathway with multiple inputs and outputs” [136].
AMPK turns on glucose uptake, fatty acid oxidation, autophagy and mitochondrial biogene-
sis and it inhibits mTOR and the synthesis of lipids and proteins. It is therefore a central regu-
lator of metabolic pathways including their effects on age-related diseases. It is also involved 
in the process of inflamm-aging via the regulation of the NLRP3 inflammasome during aging 
[138]. The capacity of AMPK signaling declines with aging which has a negative effect on the 
maintenance of cellular homeostasis [60]. Considering these facts, it is obvious that there is 
extensive research going on how to restore or boost AMPK activity by metformin [139] or by 
other nutraceutical compounds in particular polyphenols like resveratrol [140].
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4.3. Pharmacological substances
4.3.1. Metformin
Metformin is in use to treat diabetes type 2 since a long time already. The inhibitory effect on 
the synthesis of glucose in the liver is due to the activation of AMPK [141, 142]. In addition 
metformin inhibits mTOR and complex I of the mitochondrial electron transfer chain result-
ing in a reduced production of ROS. In addition metformin stimulates autophagy, dampens 
inflammatory processes and senescence and increases the lifespan in animal models [58, 143, 
144]. There are reports claiming that metformin does not only improves the healthspan and 
lifespan but also reduces the risk of some cancers and shows positive effects with congestive 
heart failure, chronic liver disease, chronic kidney disease and multiple sclerosis (summa-
rized in [145]). This had led some researchers to call metformin “the aspirin of the twenty-first 
century” [145].
4.3.2. Rapamycin
This substance has been isolated from the microorganism Streptomyces hygroscopicus which 
has been found on the island of Rapa Nui, hence the name rapamycin. It is widely used as 
an immunosuppressant to prevent rejection after organ transplantation. The protein complex 
inhibited by this substance has been termed “Target of rapamycin” or TOR and it has been 
demonstrated that it leads to a significant increase in lifespan when applied to mice and most 
other “aging” model organisms [146].
4.3.3. Resveratrol
Polyphenols are comprising a large group of plant secondary metabolites. They are classified 
into phenolic acids, lignans, flavonoids and stilbenes [147]. The most prominent member of 
stilbenes is resveratrol which is synthesized by many plants in particular in wine. Resveratrol 
activates SIRT1 which mediates the effect of caloric restriction [148]. It could be demonstrated 
that resveratrol increases the lifespan of some organisms, in mice only if they are fed a high-
fat diet [149]. In addition, resveratrol causes a number of positive effects in the cardiovascular 
system, cancer, diabetes type 2 inflammation and neurodegeneration [150]. As resveratrol is 
also stimulating autophagy and together with its neuroprotective effects, there are indica-
tions that resveratrol might also be applicable to treat Alzheimer’s disease [151]. It has to be 
mentioned that resveratrol not only activates SIRT1 but also AMPK which explains many 
of its anti-oxidant and anti-inflammatory activities [152]. Furthermore resveratrol activates a 
number of stimulus-responsive transcription factors and inhibits cAMP-degrading phospho-
diesterases which helps to understand its many effects [153–155].
4.3.4. Spermidine
Like rapamycin and resveratrol, the polyamine spermidine also stimulates autophagy 
although via a different molecular mechanism. Similar to resveratrol, the stimulation of 
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autophagy is achieved by a change in the acetylation status of several proteins, but this occurs 
in a SIRT1-independent manner (most probably due to an inhibition of acetylases) [156]. For 
spermidine too, it has been demonstrated that it is increasing the lifespan of mice and all 
“aging” model organisms [157]. Surprisingly, the amount of this substance that is present in 
all cells dramatically decreases with aging [158]. In addition spermidine has neuroprotective 
capacities [159] and reduces the risk for cardiovascular diseases [160].
Spermidine also stimulates the synthesis of anti-inflammatory cytokines and has a positive 
influence on lipid metabolism [161].
4.3.5. Vitamin D
Muscle and bone are forming a physiological unit whereby both partners are regulating each 
other via endocrine signals [162]. Vitamin D has an essential function within this regulatory 
network. A sufficient supply of vitamin D prevents loss of muscle mass (sarcopenia) and 
age-dependent deposition of fat in muscles [163, 164]. In addition vitamin D shows a posi-
tive effect on cognitive function in old age [165]. Mice lacking the vitamin D receptor do age 
prematurely and the animal model for Alzheimer’s disease show better memory performance 
and a reduction of some markers for Alzheimer’s pathology after vitamin D supplementa-
tion. Humans with Alzheimer’s disease show very low blood levels of vitamin D. Altogether 
vitamin D is a neuroprotective substance [166].
4.3.6. Soluble proteins/growth factors
Treating age-related ailments with soluble proteins is particularly attractive because it can 
be performed via simple infusions. Among the best candidates, GDF11 and oxytocin have 
demonstrated a rejuvenating effect in old mice [92]. In a study comparing very old healthy 
individuals (beyond the age of 100) with 70–80-year-old persons, a set of proteins have been 
identified whose levels were elevated in the serum of the 100+ probands. This study cor-
relates “successful aging” with these four proteins: Chemerin, Fetuin-A, FGF19 and FGF21 
[167]. In particular, FGF21 is a “systemic enhancer of longevity” [168]. It is involved in the 
coordination of glucose and lipid metabolism and maintains tissue homeostasis under stress 
conditions. FGF21 can enhance autophagy and mice overexpressing it live up to 40% lon-
ger [168]. Another good candidate to provide a healthy lifespan is adiponectin. Adiponectin 
is expressed in and secreted from small adipocytes. It increases insulin sensitivity, shows 
anti-artherosclerotic effects and improves metabolism in skeletal muscle, liver and adipose 
tissue. Adiponectin activates AMPK and SIRT1 and this way it acts like an exercise mimick-
ing factor [169]. Finally, it has to be mentioned that it also turns on catalase and superoxide 
dismutase reducing oxidative stress in metabolically active organs (summarized in [169]). A 
further “pro-youthful” factor is follistatin-like 1 (FSTL1) which together with GDF11 sup-
ports heart regeneration, as it increases the survival of cardiomyocytes [170]. Another good 
candidate is the soluble isoform of Klotho which increases the lifespan of mice and shows a 
neuroprotective function making it a good candidate for the treatment of Alzheimer’s and 
multiple sclerosis [171].
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4.3.7. Acetylcholinesterase inhibitors
Alzheimer’s disease (AD) is the most devastating aging disease. For 2013, it was estimated 
that more than 44 million people were affected worldwide and this number is expected to 
be beyond 135 million by the year 2050. Although there is presently no cure, there are a few 
drugs available that make life easier for AD patients. Most prominent are acetylcholinesterase 
inhibitors which show modest effects on improving cognitive function. The degeneration of 
cholinergic neurons which is seen in AD as well as Parkinson’s disease dementia (PDD) leads 
to a reduction of acetylcholine levels. Furthermore, cholinergic pathways are not only impor-
tant for the brain but also for skeletal muscle and the autonomous nervous system [172]. The 
increase of acetylcholine levels via inhibition of acetylcholinesterase improves cognitive func-
tion and has also beneficial effects on some of the comorbidities that usually affect AD and 
PD patients [173].
4.4. Selective elimination of senescent cells
If senescent cells are not removed by the immune system they are causing organ dysfunction 
and are a major cause of age-related diseases [174]. The removal of senescent cells in mice has 
improved their health conditions considerably. The elimination of senescent cells via drugs 
(senolysis) [175] or to trigger apoptosis (senoptosis) is also a realistic possibility in humans. 
From the observation that senescent cells do not respond to their own pro-apoptotic SASP, 
it was concluded that they have senescent-cell anti-apoptotic pathways (SCAPs). Six such 
SCAPs have been identified and these SCAPs were then screened for targets sensitive to seno-
lytic drugs [176]. A number of senolytic drugs synthetic ones as well as of plant origin have 
been identified in the meantime. Prominent among them is quercetin which demonstrates 
promising activities [166]. It has to be mentioned that not every senolytic drug is effective on 
each senescent cell type and often is the combination of two or three drugs much more effec-
tive. An advantage over other medications is that senolytic drugs need not be taken continu-
ously to exert their effect but just administered intermittently [176]. The use of senolytic drugs 
increase hope for the treatment of diseases for which there are hardly any other therapeutic 
options like idiopathic pulmonary fibrosis (IPF) a devastating lung disease [177]. Another 
elegant approach to trigger apoptosis in senescent cells has recently been demonstrated using 
a synthetic peptide. This cell penetrating peptide (CPP) was deduced from the sequence of the 
transcription factor FOXO4 and it excludes p53 from the nucleus. Instead of residing in the 
nucleus p53 is docking on to mitochondria to trigger apoptosis [178]. An additional possibility 
is to attack senescent cells with specific antibodies or by modified T cells [9].
4.5. Transplantation of stem cells
Stem cells are of utmost importance for regeneration and function of all organs. Transplanting 
stem cells into target tissues opens the possibility to repair major defects. Here we are at the 
brink of breathtaking possibilities for regenerative medicine. In particular, multipotent mes-
enchymal stem cells offer a wide spectrum of applications however these cells are loosing a 
lot of their regenerative capacity during aging [179]. Substantial progress has been made by 
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the discovery that only four transcription factors (OCT3/4, SOX2, KLF4 and MYC) can induce 
reprogramming to pluripotency. Somatic cells can be transformed into young embryonic 
stem cells (induced pluripotent stem cells = iPSCs) [180]. From human fibroblasts such iPSCs 
could be generated and after specific differentiation processes used in different tissues [181]. 
In clinical trials, specific cells have been differentiated from iPSCs to treat Alzheimer disease, 
Parkinson disease, spinal cord injuries, diabetes or congestive heart failure [182]. Such a strat-
egy for rejuvenation of old organs via stem cell therapy offers possibilities almost without 
limits for the future [183]. There is, however, a number of points that critically affects the 
success of stem cell transplantation. No matter how the replacement cells have been gener-
ated either as induced pluripotent stem cells (iPSCs) and subsequent differentiation steps or 
by direct transdifferentiation of somatic cells the condition of the stem cell niche is of utmost 
importance for regenerative success [183]. Also protein factors of the circulation effect trans-
planted cells massively [184]. Furthermore inflammatory processes which are often increased 
during aging effect stem cells dramatically as has been demonstrated for satellite cell function 
[185]. This demands the inhibition of inflammatory signaling as absolutely necessary.
5. Conclusion
Since the turn of the century there has been enormous progress in aging research in many 
fields. In this book chapter, we made a selection of aging theories and pathways that in our 
opinion are of great importance. To name them all would by far go beyond the scope of this 
article. It also has to be stated that of all the organelles in the cell we did just name mitochon-
dria and their role in the aging process. But there is rising knowledge that all organelles have 
their specific share to aging. In the focus of this article were especially pathways and mecha-
nisms on the cellular level. We did neglect that basically each organ and tissue has its private 
aging mechanisms [186, 187]. Therefore we believe that aging research will move on from cells 
toward tissues/organs and whole organisms. The possibilities that epigenetics will provide to 
increase health span look breathtaking, however, they cannot be really estimated to their full 
extend today yet. Much more realistic seems the application of stem cells which will provide 
regenerative medicine with fabulous opportunities. A very positive effect for an increased 
healthspan for almost all people will be possible if we will be able to boost autophagy without 
side effects. A similar effect on health span and the prevention of age-related diseases can be 
expected if it will be possible to eliminate senescent cells. Taken together there are really good 
chances that in the near future it will be possible to help many humans to live a healthy aging.
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